Popular Articles

FDA Approves Sculptra(R)Aesthetic, A Facial Injectable For Correction Of Nasolabial Folds And Other Facial Wrinkles
Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) approved Sculptra(R)Aesthetic (injectable poly-L-lactic acid) for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles which are treated with the appropriate injection technique in healthy patients. Sculptra(R)Aesthetic works gradually to offer natural-looking results that can last up to two years.

Chemotherapy Plus Radiotherapy, With Or Without Surgery, Are Options For Patients With Stage Iiia (N2) Non-Small-Cell Lung Cancer
An Article published Online First and in an upcoming edition of The Lancet concludes that radiotherapy plus chemotherapy, with or without surgery, are both treatment options for patients with stage IIIA (N2) non-small-cell lung cancer. The Article is written by Dr Kathy Albain, Loyola University Chicago Stritch School of Medicine, Cardinal Bernardin Cancer Center, Maywood, IL, USA, and colleagues.
News of the day
Mylan Again Calls For An End To Authorized Generics During 180-Day Exclusivity Period
Mylan Inc."s (NASDAQ: MYL) Chief Operating Officer Heather Bresch today testified before the U.S. House of Representatives Judiciary Subcommittee on Courts and Competition Policy concerning patent litigation settlements between branded pharmaceutical companies and generic pharmaceutical companies. During her testimony, Bresch conveyed Mylan"s position that the launch of an authorized generic by brand companies during a generic company"s 180-day exclusivity period undermines competition and delays timely access to high quality, affordable generic medications for patients, taxpayers, the government and businesses.
Cardiovascular

Studying Human Behavior May Be Key To Tackling Swine Flu

Researchers from The University of Texas at Austin will participate in a $3 million, five-year grant from the National Institutes of Health (NIH) to fight influenza and other diseases by creating models that simulate the complex interplay between human behavior and the spread of disease. The grant is part of the Models of Infectious Disease Agent Study (MIDAS) program, a national network of researchers using mathematical models to help public health officials better predict, intervene and contain contagious diseases. Researchers from Texas include Lauren Ancel Meyers, a mathematical biologist in the College of Natural Sciences and Paul Damien, a mathematician in the McCombs School of Business. Meyers is leading the project jointly with Allison Galvani at Yale University. The group already has begun work this summer. They are trying to understand how to best use the national stockpile of flu antiviral medications such as Tamiflu and Relenza for the current H1N1 pandemic (swine flu). Between state and federal holdings, there are approximately 80 million courses of these drugs available. "Who should be taking these antivirals? And when? What are the optimal choices to best save lives and prevent the spread of the swine flu?" Meyers said. "Our models can help answers those questions." The group has also launched a survey-based study to learn how perceptions and behavior evolve as information about the H1N1 pandemic spreads around the globe through the media. Meyers said that as people change things like travel plans, they in turn change how the disease spreads. Additionally, Damien said, "Take school closures as an example. It"s challenging to assess when and where to close schools. Based on what metric? Percent infected? Percent likely to be infected? Only by using mathematical methods can we best quantify these uncertainties. The MIDAS program rightly encourages the use of mathematics to make better, informed decisions, and we"re excited to be involved in such an effort." Thus, there are many factors that can affect the spread of diseases including population densities, closures of schools and public places, how drugs and vaccines are distributed, cost of treatments and people"s perceptions of vaccines. "Our models will combine these factors and allow us to design public health policies that not only use res effectively but also influence individual decision making to prevent the transmission of diseases like flu," Meyers said. Lee Clippard University of Texas at Austin


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):